Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use

A compound, -R2 technology, applied in the direction of active ingredients of heterocyclic compounds, medical preparations containing active ingredients, and drug combinations, which can solve the problems of complex toxicity assessment and affecting developability.

Pending Publication Date: 2021-05-14
现代生物科学有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, biarylsulfonamide metabolites acted as metabolic inducers in rats, complicating the assessment of their toxicity in rodents, which in turn may affect the compound's developability for use in humans

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use
  • 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use
  • 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0113] Some embodiments of the invention include the following:

[0114] (1) Compounds of the following formula:

[0115]

[0116] or a pharmaceutically acceptable salt or solvate thereof;

[0117] in:

[0118] =X- is independently -CH= or -N=;

[0119] -R 1 independently -H or -R 1X ;

[0120] -R 1X independently -F, -Cl, -R 1C ,-R 1F or -CN;

[0121] -R 1C independently saturated linear or branched C 1-3 alkyl;

[0122] -R 1F independently saturated linear or branched C 1-3 Fluoroalkyl;

[0123] -R 2 independently -H or -R 2X ;

[0124] -R 2X independently -F, -Cl, -R 2C ,-R 2F or -CN;

[0125] -R 2C independently saturated linear or branched C 1-3 alkyl;

[0126] -R 2F independently saturated linear or branched C 1-3 Fluoroalkyl;

[0127] -R 3 independently -H or -R 3X ;

[0128] -R 3X independently -F, -Cl, -R 3C ,-R 3F or -CN;

[0129] -R 3C independently saturated linear or branched C 1-3 alkyl;

[0130] -R 3F independently satura...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
wavelengthaaaaaaaaaa
wavelengthaaaaaaaaaa
Login to View More

Abstract

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds (collectively referred to herein as CHMSA compounds) that are useful, for example, in the treatment of disorders (e.g., diseases) including, e.g., multiple myeloma, diffuse large B-cell lymphoma, acute myeloid leukemia, eosinophilic leukemia, glioblastoma, melanoma, ovarian cancer, chemotherapy resistant cancer, radiation resistant cancer, inflammatory arthritis, rheumatoid arthritis, psoriatic arthritis, psoriasis, ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), lupus nephritis, asthma, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), autoimmune hepatitis, hidradenitis suppurativa, etc. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, for example, in therapy.

Description

[0001] related application [0002] This application relates to British (GB) patent application No. 1813312.4 filed on August 15, 2018, the contents of which are incorporated herein by reference in its entirety. technical field [0003] The present invention relates generally to the field of therapeutic compounds. More specifically, the present invention relates to certain substituted 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexanols and 1-methyl-4-[[4-(2- Pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds (collectively referred to herein as CHMSA compounds), which are useful, for example, in the treatment of disorders (e.g., diseases) including, for example, multiple myeloma, diffuse large B-cell Lymphoma, acute myeloid leukemia, eosinophilic leukemia, glioblastoma, melanoma, ovarian cancer, chemotherapy-resistant cancer, radiation-resistant cancer, inflammatory arthritis, rheumatoid arthritis, psoriasis Arthritis, psoriasis, ulcerative colitis, Crohn's disease, sy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/61A61P19/00A61P35/00A61P37/00A61K31/44C07C317/32
CPCC07D213/61A61P35/00A61P37/00A61P19/00C07C317/44C07C317/18C07C317/14A61K31/10A61K31/4418A61P29/00C07C2601/14C07C317/22C07C317/36C07D213/06
Inventor 利萨·帕特尔斯蒂芬·艾伦·史密斯
Owner 现代生物科学有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com